本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Passage Bio, Inc.

0.3500
-0.0077-2.15%
盘后0.36440.0144+4.11%16:18 EDT
成交量:18.43万
成交额:6.32万
市值:2,175.19万
市盈率:-0.33
高:0.3600
开:0.3600
低:0.3320
收:0.3577
数据加载中...

公司资料

公司名字:
Passage Bio, Inc.
交易所:
NASDAQ
成立时间:
2017
员工人数:
60
公司地址:
One Commerce Square,2005 Market Street,39th Floor,Philadelphia,Pennsylvania,United States
邮编:
19103
传真:
- -
简介:
Passage Bio, Inc.是一家位于特拉华州的公司,成立于2017年7月26日,是一家专注于开发罕见的单基因中枢神经系统疾病的转化疗法的基因药物公司。其愿景是成为领先的基因药物公司,并积极改变因为遭受这些疾病而受到生命威胁的患者生活。

董事

名称
职位
Bruce Goldsmith
Chief Executive Officer, President and Director
Stephen Squinto
Acting Head of Research and Development and Director
Athena Countouriotis
Director
Liam Ratcliffe
Director
Patrick Heron
Director
Sandip Kapadia
Director
Saqib Islam
Director
Tadataka Yamada
Director
Tom Woiwode
Director

股东

名称
职位
Bruce Goldsmith
Chief Executive Officer, President and Director
Jill M. Quigley
Chief Operating Officer
Richard S. Morris
Chief Financial Officer
Alex Fotopoulos
Chief Technical Officer
Edgar B. Cale
General Counsel and Corporate Secretary
Gary Romano
Chief Medical Officer
Stephen Squinto
Acting Head of Research and Development and Director